skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Excited delirium: Consideration of selected medical and psychiatric issues

Rapid Communication

(4923) Views  (1019) Full article downloads

Authors: Edith Samuel, Robert B Williams, Richard B Ferrell

Published Date January 2009 Volume 2009:5 Pages 61 - 66
DOI: http://dx.doi.org/10.2147/NDT.S2883

Edith Samuel1, Robert B Williams1, Richard B Ferrell2

1Department of Psychology, Atlantic Baptist University, Moncton, New Brunswick Canada; 2Department of Psychiatry, Dartmouth Medical School, Lebanon, New Hampshire, USA

Abstract: Excited delirium, sometimes referred to as agitated or excited delirium, is the label assigned to the state of acute behavioral disinhibition manifested in a cluster of behaviors that may include bizarreness, aggressiveness, agitation, ranting, hyperactivity, paranoia, panic, violence, public disturbance, surprising physical strength, profuse sweating due to hyperthermia, respiratory arrest, and death. Excited delirium is reported to result from substance intoxication, psychiatric illness, alcohol withdrawal, head trauma, or a combination of these. This communication reviews the history of the origins of excited delirium, selected research related to its causes, symptoms, management, and the links noted between it and selected medical and psychiatric conditions. Excited delirium involves behavioral and physical symptoms that are also observed in medical and psychiatric conditions such as rhabdomyolysis, neuroleptic malignant syndrome, and catatonia. A useful contribution of this communication is that it links the state of excited delirium to conditions for which there are known and effective medical and psychiatric interventions.

Keywords: excited delirium, excited states, cocaine misuse, restraint or in custody deaths








Readers of this article also read:

Restless legs syndrome: differential diagnosis and management with rotigotine
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran
Hyperbaric oxygen ameliorates worsening signs and symptoms of post-traumatic stress disorder
A gender difference in circulating neutrophils in malnourished patients with COPD
Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
TachoSil use in abdominal surgery: a review
Romidepsin in the treatment of cutaneous T-cell lymphoma
Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations
Breast manifestations of systemic diseases